Linagliptin
FDA Approved: * November 3, 2025Pharm Company: * AUROBINDO PHARMA LTD
Category: Diabetes
Linagliptin, sold under the brand name Trajenta among others, is a medication used to treat diabetes mellitus type 2.[4][5] It is generally less preferred than metformin and sulfonylureas as an initial treatment.[4][6] It is used together with exercise and diet.[4] It is not recommended in type 1 diabetes.[4] It is taken by mouth.[4] Common side effects include inflammation of the n... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.1 Discussion
Dosage List
Related Brands
Drugs with the same active ingredientsPopular Topics
trajenta linagliptin
what is deference between istamet and trajenta and side effects...